Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
13 oct. 2020 09h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, Md, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...